Literature DB >> 35015750

Is a Mechanical Rotational Chair Superior to Manual Treatment Maneuvers on an Examination Bed in the Treatment of Benign Paroxysmal Positional Vertigo?

Alexander Schuricht1,2, Dan Dupont Hougaard1,2.   

Abstract

OBJECTIVE: To compare the efficacy of the TRV-chair, a mechanical rotational chair, against manual treatment maneuvers in the treatment of benign paroxysmal positional vertigo (BPPV). STUDY
DESIGN: Prospective open-label block-randomized controlled clinical trial.
SETTING: Tertiary referral center.
SUBJECTS: Seventy-four patients referred from primary care and subsequently diagnosed with BPPV.
INTERVENTIONS: Patients were randomized to diagnostics and treatment with either manual treatment maneuvers on an examination table or using the TRV-chair. MAIN OUTCOMES: The primary outcome was treatment efficacy, defined as absence of positional nystagmus (with or without concomitant vertigo), following one treatment. Secondary outcomes were number of treatments necessary for treatment success and Dizziness Handicap Inventory (DHI) scores.
RESULTS: 61.1% of the subjects in the TRV-group and 63.2% in the manual treatment group were treated successfully (p = 0.856). The differences in the number of treatments necessary to achieve treatment success as well as pre- and post-treatment DHI-scores between the TRV-group and the manual treatment group were nonsignificant.
CONCLUSIONS: Traditional manual treatment maneuvers and treatment maneuvers performed with the TRV-chair are equally good at treating BPPV in patients referred directly from primary care.
Copyright © 2021, Otology & Neurotology, Inc.

Entities:  

Mesh:

Year:  2022        PMID: 35015750     DOI: 10.1097/MAO.0000000000003380

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  1 in total

1.  Seven years of experience with treatment of benign paroxysmal positional vertigo with a mechanical rotational chair.

Authors:  Dan Dupont Hougaard; Sebastian Hygum Valsted; Niels Henrik Bruun; Mathias Winther Bech; Michel Heide Talebnasab
Journal:  Front Neurol       Date:  2022-08-25       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.